Phenylalanine exacerbates psoriasiform inflammation through NF‑κB‑mediated dendritic cell activation and Th17 polarization
Authors:
Open Access
- 8 July 2026
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 58 (3) , 1-14
Abstract
Metabolic dysregulation has been increasingly recognized as a key driver in the pathogenesis of psoriasis; however, the specific mechanistic contributions of amino acid perturbations remain poorly understood. The present study, through comprehensive metabolomic profiling, observed a marked accumulation of phenylalanine in both the circulation and skin lesions of psoriatic mice. Notably, a high‑phenylalanine diet exacerbated psoriasiform skin inflammation of imiquimod‑induced psoriasis, whereas dietary restriction of phenylalanine or administration of L‑type amino acid transporter inhibitors effectively alleviated skin inflammation. Mechanistically, transcriptome sequencing of dendritic cells identified phenylalanine as a potent metabolic trigger. The present analysis revealed that high phenylalanine levels alone significantly elevated the baseline expression of notable pro‑inflammatory cytokines and this inflammatory response was further amplified in the presence of imiquimod. The present study determined that this pro‑inflammatory effect was mediated through the NF‑κB signaling pathway, which subsequently promoted the differentiation of T helper 17 cells. Collectively, the present findings uncovered a previously unrecognized metabolic checkpoint in psoriasis and suggested that restriction of phenylalanine represents a promising, non‑toxic adjunctive therapeutic strategy for the clinical management of psoriasis.Keywords
This publication has 48 references indexed in Scilit:
- Metabolic regulation of the immune cell in psoriasis: mechanisms and interventionsCurrent Opinion in Immunology, 2025
- Role of glucose metabolism reprogramming in keratinocytes in the link between psoriasis and metabolic syndromeInternational Immunopharmacology, 2024
- Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre StudyAmerican Journal of Clinical Dermatology, 2024
- Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic ReviewAmerican Journal of Clinical Dermatology, 2022
- Pathophysiology, Clinical Presentation, and Treatment of PsoriasisJAMA, 2020
- Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis FoundationJAMA Dermatology, 2018
- Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patientsInternational Journal of Developmental Neuroscience, 2015
- Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis†Hepatology, 2009
- Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global AssessmentJournal of the American Academy of Dermatology, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001